F. Fitoussi

1.1k total citations
35 papers, 814 citations indexed

About

F. Fitoussi is a scholar working on Epidemiology, Surgery and Infectious Diseases. According to data from OpenAlex, F. Fitoussi has authored 35 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 12 papers in Surgery and 11 papers in Infectious Diseases. Recurrent topics in F. Fitoussi's work include Pneumonia and Respiratory Infections (12 papers), Streptococcal Infections and Treatments (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). F. Fitoussi is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Streptococcal Infections and Treatments (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). F. Fitoussi collaborates with scholars based in France, Gabon and Democratic Republic of the Congo. F. Fitoussi's co-authors include Édouard Bingen, G.-F. Penneçot, C. Doit, Keyvan Mazda, N. Brahimi, Robert Cohen, Pierre Geslin, Chawki Loukil, Stéphane Bonacorsi and Dominique Deforche and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

F. Fitoussi

35 papers receiving 776 citations

Peers

Countries citing papers authored by F. Fitoussi

Since Specialization

Citations

This map shows the geographic impact of F. Fitoussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Fitoussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Fitoussi more than expected).

Fields of papers citing papers by F. Fitoussi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Fitoussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Fitoussi. The network helps show where F. Fitoussi may publish in the future.

Co-authorship network of co-authors of F. Fitoussi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Fitoussi. A scholar is included among the top collaborators of F. Fitoussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Fitoussi. F. Fitoussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conventional versus fibrin-glue-augmented arterial microanastomosis: An experimental study 2022 ·Hand surgery & rehabilitation ·Malo Le Hanneur, (unknown), (unknown), (unknown), P. Bouché, F. Fitoussi	2
2	Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS‐CoV‐2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France 2021 ·Infection ·F. Fitoussi, Serge Tonen‐Wolyec, (unknown), (unknown), Laurent Bélec	2
3	Upper extremity kinematics analysis in obstetrical brachial plexus palsy 2009 ·Orthopaedics & Traumatology Surgery & Research ·F. Fitoussi, Nathalie Maurel, Amadou Diop, (unknown), Brice Ilharreborde, Ana Presedo, Keyvan Mazda, G.-F. Penneçot	21
4	Marqueurs de l'inflammation et infection ostéoarticulaire 2007 ·Archives de Pédiatrie ·Mathie Lorrot, F. Fitoussi, Albert Faye, Pier Paolo Mariani, C Job-Deslandre, G.-F. Penneçot, Édouard Bingen, A Bourrillon	26
5	Concordance of antibiotic prophylaxis, direct Gram staining and protected brush specimen culture results for postoperative patients with suspected pneumonia 2006 ·European Journal of Anaesthesiology ·(unknown), F. Fitoussi, (unknown), (unknown), D Brodaty	1
6	Resistance to macrolides in Group A streptococci from the European section of Turkey: genetic and phenotypic characterization 2002 ·International Journal of Antimicrobial Agents ·Filiz Akata, Dilek Öztürk, (unknown), Müşerref Tatman‐Otkun, Metin Otkun, F. Fitoussi, Édouard Bingen, (unknown)	9
7	Systematic pinning of displaced extension-type supracondylar fractures of the humerus in children 2001 ·Journal of Bone and Joint Surgery - British Volume ·Keyvan Mazda, (unknown), F. Fitoussi, G.-F. Penneçot	92
8	High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children 2001 ·The Pediatric Infectious Disease Journal ·George A. Syrogiannopoulos, (unknown), F. Fitoussi, C. Doit, (unknown), Édouard Bingen, Nicholas G. Beratis	33
9	Ulcère de Buruli : une pathologie d’exportation 2000 ·Archives de Pédiatrie ·(unknown), F. Fitoussi, (unknown), G.-F. Penneçot, A Bourrillon	1
10	Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis 1999 ·Antimicrobial Agents and Chemotherapy ·Stéphane Bonacorsi, F. Fitoussi, (unknown), Édouard Bingen	49
11	Killing Activities of Trovafloxacin Alone and in Combination with β-Lactam Agents, Rifampin, or Vancomycin against Streptococcus pneumoniae Isolates with Various Susceptibilities to Extended-Spectrum Cephalosporins at Concentrations Clinically Achievable in Cerebrospinal Fluid 1999 ·Antimicrobial Agents and Chemotherapy ·F. Fitoussi, C. Doit, Pierre Geslin, Édouard Bingen	12
12	Flexor Tendon Injuries in Children: Factors Influencing Prognosis 1999 ·Journal of Pediatric Orthopaedics ·F. Fitoussi, (unknown), (unknown), G.-F. Penneçot	38
13	EFFECTS OF ORAL SACCHAROMYCES BOULARDII (SB) ON BACTERIAL OVERGROWTH, TRANSLOCATION AND INTESTINAL ADAPTATION AFTER SMALL BOWEL RESECTION IN GROWING RATS. 1998 ·Journal of Pediatric Gastroenterology and Nutrition ·A Zaouche, Chawki Loukil, M. Peuchmaur, J. Macry, Pascal de Lagausie, F. Fitoussi, Henri Bléhaut, Paul Bernasconi, Édouard Bingen, (unknown)	6
14	Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure ofStreptococcus pyogenes pharyngitis 1997 ·European Journal of Clinical Microbiology & Infectious Diseases ·F. Fitoussi, Robert Cohen, G. Brami, C. Doit, N. Brahimi, F. de La Rocque, Édouard Bingen	11
15	Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis 1996 ·The Pediatric Infectious Disease Journal ·Robert Cohen, Corinne Lévy, C. Doit, F. de La Rocque, M. Boucherat, F. Fitoussi, J. Langue, Édouard Bingen	58
16	Escherichia hermannii: susceptibility pattern to β-lactams and production of β-lactamase 1995 ·Journal of Antimicrobial Chemotherapy ·F. Fitoussi, Guillaume Arlet, Patrick A. D. Grimont, P. H. Lagrange, A. Philippon	10
17	Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile 1995 ·Antimicrobial Agents and Chemotherapy ·F. Fitoussi, C. Doit, Anna Sandin, A. Péchinot, (unknown), P. Geslin, Édouard Bingen	9
18	[Hollow femoral trochlea and femoro-patellar osteoarthritis]. 1994 ·PubMed ·F. Fitoussi, (unknown), (unknown), (unknown)	4
19	Activité inhibitrice de différentes concentrations d'acide clavulanique, de tazobactam et de sulbactam vis-à-vis de 117 souches d'entérobactéries productrices de β-lactamase 1993 ·Médecine et Maladies Infectieuses ·F. Fitoussi, Guillaume Arlet, I Casin, P. H. Lagrange, A. Philippon	2
20	[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]. 1988 ·PubMed ·(unknown), J L Pico, D. Chiche, F. Fitoussi, Alain Delmer, D Baume, Bernard Rio, (unknown), Hervé Richet, C Tancrède	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact